Drug Approval | April 29, 2024
The Product is expected to be the first generic approval on the market
This partnership combines Tata Elxsi's design and technology expertise along with Dräger's expertise in medical and safety technology
Both organisations enter into a long- term collaboration to expand patient access in India
This is the first and only oral once-a-day therapy for testosterone suppression in patients with advanced prostate cancer in India
The launch will enable PCC to further expand their existing Zinc Sulfate Injection product line and overall the generic injectables portfolio
He is also inducted as a member of the management council and senior management personnel of the company
New effective carrier systems for drug delivery in different dosage applications including oral, topical & parenteral
Punit has more than 20 years of experience in the generics and branded pharmaceutical marketplace
Subscribe To Our Newsletter & Stay Updated
